Sulforaphane Alleviates Psoriasis by Enhancing Antioxidant Defense through KEAP1-NRF2 Pathway Activation and Attenuating Inflammatory Signaling

In vitro experiments using HaCaT cells demonstrated that sulforaphane inhibited IL-22 and TNF-α-induced activation of inflammatory pathways and keratinocyte proliferation.